Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | Novel immunotherapy approaches in lymphoma: CAR-T cells, bispecifics & sequencing

Gloria Iacoboni • 15 Apr 2024
EBMT 2024
Follicular Lymphoma Lymphoma Non-Hodgkin Lymphoma Antibodies CAR-T

In this video, Gloria Iacoboni, MD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, gives an overview of novel immunotherapy approaches in lymphoma, including CAR-T cells and bispecific antibodies. Dr Iacoboni highlights the encouraging results which have been observed with the use of these agents, and further comments on the optimal sequencing of these therapies. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Gloria Iacoboni

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
2:02
Impact of prior bendamustine exposure on BsAb treatment outcomes in patients with B-cell lymphoma
Gloria Iacoboni • 10 Dec 2023
1:12
Prior treatment with BsAb does not impair response to CAR-T in patients with large B-cell lymphoma
Gloria Iacoboni • 10 Dec 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals